Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dermaclara is a private San Diego-based skincare and consumer health company commercializing reusable medical-grade silicone occlusion patches and related skincare products. The brand markets products for wrinkles, fine lines, stretch marks, scars, skin laxity, and other cosmetic skin concerns, with a core proposition centered on creating an occlusive microclimate to improve hydration and support collagen and skin elasticity. Its portfolio includes face, neck, belly, chest, scar, and body patch kits, along with complementary cleansers, moisturizers, oils, and lip products. Dermaclara appears to operate as a direct-to-consumer beauty brand rather than a traditional drug-development biotech or pharma company, with products already on the market and sold through its own website and e-commerce channels.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dermaclara.